CircHIPK3: a promising cancer-related circular RNA

Yalu Zhang1, Qiaofei Liu1, Quan Liao1

  • 1Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100730, China.

Insights

Circular RNAs (circRNAs) are unique noncoding RNAs involved in cancer. CircHIPK3, a specific circRNA, shows potential as a diagnostic and prognostic biomarker in various malignancies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Circular RNAs (circRNAs) are noncoding RNAs with a distinct looped structure.
  • Aberrant circRNA expression is linked to human cancers, acting as oncogenes or tumor suppressors.
  • CircHIPK3 (circRNA homeodomain-interacting protein kinase 3) is implicated in multiple cancers.

Purpose of the Study:

  • To review the mechanisms and functions of circHIPK3 in cancer progression.
  • To highlight circHIPK3's role as a potential biomarker and therapeutic target.

Main Methods:

  • Literature review of studies on circHIPK3 and cancer.
  • Analysis of circHIPK3's function as a miRNA sponge.
  • Examination of circHIPK3's involvement in cell proliferation, invasion, and migration.

Main Results:

  • CircHIPK3 acts as a miRNA sponge, regulating target genes.
  • CircHIPK3 influences key cancer processes like proliferation and migration.
  • CircHIPK3 demonstrates potential as a diagnostic, prognostic, and therapeutic marker.

Conclusions:

  • CircHIPK3 plays a significant role in the development and progression of various cancers.
  • CircHIPK3 represents a promising target for cancer diagnostics and therapeutics.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.9K